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TECHNICAL MEMORANDUM
PROSTHETIC DEVICE FOR CORRECTION OF
URINARY INCONTINENCE
I. INTRODUCTION AND BACKGROUND
The National Aeronautics and Space Administration (NASA)
encountered many biomedical problems by placing man in an alien environ-
ment. As these problems were resolved, it became apparent that much
of the technology developed was almost directly applicable to biomedical
problems existing on Earth. Not so apparent was the fact that the same
technology requirements for high reliability, durability, and minimum
size and weight for aerospace advanced the technology needed in bio-
medical innovations.
For these reasons, in 1966, NASA created the Biomedical Applica-
tion Team Program, in which interdisciplinary teams actively seek out
medical problems to which solutions may be found within the aerospace
community. The teams interact with major medical institutions throughout
the United States and define specific technological barriers to medical
progress. The teams then propose solutions to these problems utilizing
the technology which has been developed for the space: program.. This
article is a typical outgrowth of that process.
Developing a device to be implanted inside the human body is a
complex undertaking. Therefore, NASA's contribution was not only to
provide the innovative concept and aerospace technology, but also to pull
together the team of industries and institutions to take the project through
design, development, manufacturing, animal trials, clinical trials, and
marketing.
Urinary incontinence is one of the most difficult problems facing
urologists today. It occurs in patients of both sexes and at all ages.
For this article, incontinence can be defined as the involuntary loss of
urine. The anatomy of the lower urinary tract consists of (1) the
bladder which serves to store urine and forcibly expel it at regular and
appropriate intervals and (2) the sphincter mechanism which surrounds
and constricts the urethra, preventing urine from escaping when it
should not. There is a balance between the mechanism for expulsion of
urine and the mechanism necessary for its retention, and incontinents
ensues when the balance is upset. Incontinence can thus be divided
into two types:
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a) Incontinence which occurs when the bladder is abnormal
b) Incontinence which occurs when the sphincter mechanism is
incompetent.
The most common form of incontinence in young, healthy, and
nulliporous (childless) women is stress incontinence which occasionally
occurs in as many as 50 percent and frequently occurs in approximately
5 percent. This condition at times is worsened by child bearing [1].
Detrusor (bladder contraction muscle) abnormality is also common in
women, and of those with stress incontinence 48 percent have an
abnormal detrusor [2]. In men, sphincter incompetence sometimes follows
prostatectomy, while detrusor dysfunction is most commonly caused by
disseminated sclerosis, cerebrovascular accidents (stroke), and spinal
trauma. Other causes such as spinal cord tumor, degenerative disease
of the spinal cord, cervical spondylosis , head injury, herniated inter-
vertebral disc, syringomyelis, and tabes dorsalis contribute a small but
significant number of cases.
Table 1 indicates the large number of patients who lost bladder
function as a sequel to a variety of diseases or injuries,
TABLE 1. MAJOR CAUSES OF INCONTENANCE [3]
Disease or Injury
Estimated
total cases
Incidence of
cases with
bladder dys-
function M
Estimated total
cases with neuro-
logic dysfunction
of urinary bladder
Multiple sclerosis 500,000 90 450,000
Spinal cord injury 100,000 75 75,000
Cerebrovascilar disease 2,000,000 10 200,000
Parkinson's disease 1,000,000 25 250,000
Diabetes mellitus 3,000,006 10 300,000
Meningo myelocoele 11000 75 750
Amyotrophic lateral
sclerosis 61000
 10 600
TOTAL 1,276, 350
The Rehabilitition Services Administration estimates that spinal cord
injury cases alone are increasing at the rate of 8,000 to 10,000 each year
with 80 percent of these in the 15 to 30 age range. Costs of care for
spinal cord victims are estimated at $2.4 billion per year [4].
Current efforts to manage the incontinent patient consist of external
collection devices or the use of an indwelling catheter. The most widely
used external collection device at this time is the diaper. The obvious
disadvantages of this system are (1) a social embarrassment as a result
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of the odor (many patients avoid a return to working or social contacts
as a result) , and (2) the constant presence of urine results in skin
rashes and severe skin ulcers.
The external collection device currently used for the male consists
of a roll-on cuff with a connector to a leg bag for storage. As yet, no
device is available for external collection of urine from the female. NASA
Is currently sponsoring research using aerospace technology to develop
a method for externally collecting and storing urine for incontinent
females. The major disadvantage of external collection devices is the
constant presence of residual urine in the bladder and urethra, a con-
dition that encourages bacterial growth. As a result, kidney failure
resulting from urinary tract infections is a major cause of death in
patients with spinal cord injury as well as others with severe urinary
incontinence. Another means of managing urinary incontinence is through
the use of indwelling catheters. This method has the disadvantages of
requiring confinement to a bed as well as serving as a source of infection.
A need exists for a device that will allow the bladder to fill and
then be emptied rapidly every 3 or 4 hours. This periodic voiding allows
the bladder muscles to be exercised and, as a result, to remain healthy.
In addition, the problem of residual urine is eliminated, and the urethra
remains closed except during voiding so that the risk of urinary tract
and kidney infections is greatly decreased. A prosthetic urinary
sphincter being developed by NASA will fill this need. This sphincter
will provide voluntary urination control to both male and female patients
of any age 12 years and up who are healthy enough to undergo the
implantation surgery.
11. PROBLEM STUDY
After receiving a problem statement from the Biomedical Applica-
tions Team, a MEDLINE search was made to determine all documented
effort that had been expended on this problem. Some 30 related articles
were thus obtained and evaluated providing an up-to-date background
as a base from which to start. A survey was then made on NASA's
programs to determine if any valves or systems that might be applicable
to a prosthetic urinary sphincter were in existence. It was found that
no hardware could be directly applied; however, there were miniature
valves that could be used with modification. Qualified suppliers were
then consulted with regard to their interest in participating in a develop-
ment program and they were also asked for suggestions for applying
their technology to assure a reliable producible unit. A study was then
made on biocompatible materials. The development of polymeric materials
compatible with a wide variety of acidic and caustic solutions used in the
space program opened the potential for body implants.
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After reviewing the prosthetic urinary sphincter designs described
In the MEDIINE search articles and surveying the aerospace industries
technology, it was concluded that NASA could make significant contribu-
tions toward an acceptable unit in two areas — first, by increasing the
unit's reliability: second, by producing a simplified system that would
reduce the trauma of implantation. The following design ground rules
were then generated to help avoid the problems encountered by other
attempts to restore urinary continence:
a) Minimize surgery for implantation — The implantation could be
done perfectly, yet if the body is traumatized excessively, recovery will
require much more time, or worse, implant removal might be required
before the body would heal. Also, the longer the operation, the greater
the chances of contracting a serious infection.
b) The design shall be simple for maximum reliability — Reduce
friction and stiction by eliminating sliding parts. Minimum number of
moving parts reduces the number of possible failure modes.
c) Design the urethral cuff so it will be adjustible after implanta-
tion — This reduces the time required for implantation and also eliminates
chance of misfit. I f this cuff is tort large there will be no control. If
the cuff is too small, blood circulation is cut off'. re-sulting in necrosis
(tissue death) .
d) The design shall .
 use only proven compatible materials to avoid
the expense and time required for compatibility testing of a new material.
e) The design shall be such that the recipient's sexual activity
will not be hampered.
f) Make design differences for male and female if necessary.
Packaging differences may be necessary due to anatomy differences.
g) Consider both mechanical and hydraulic designs for putting
the force on the urethra. The selection could be based on the other
design ground rules with special emphasis on precise cuff pressure
control and reliability.
h) The compression on the urethral cuff shill have minimum drift
to avoid loss of urine over a long period of time such as sleep period.
i) 'rhe connecting tube between the cuff and the controls shall
have maximum flexibility to allow it to conform, without kinking, to the
body configuration.
j) The design ~hall be such that it can be manufactured by use
of established technology.
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k) The design shall be such that the critical functioning parts
will not be contaminated with blood which is obviously present during
implantation.
1) If tubing connections during the surgical procedure are
required, they should be designed for minimum risk of contamination and
minimum time required to perform. The implant ideally would not require
any connections.
m) The urethral cuff shall be of minimum size thereby requiring
the least disturbance and rearrangement of adjacent parts of the body.
Trade-off shall be made, however, with contact area versus force
required to establish continence.
n) The control actuator shall be sized to be cosmetically nonintru-
sive, yet large enough for easy through-the -skin finger thumb operation.
To accomplish the objectives, an encircling cuff will be implanted
which will provide enough squeeze on the urethra to restore continence,
yet remain below the pressure that would cause necrosis. The controls
for the cuff will be located in the scrotum for the male and the labium
major for the female (Figs. 1 and 2). The complete assembly will be
totally implanted. Through-the-skin pressure will actuate valve for
periodically voiding the bladder.
Many concepts evolved from which five of the most promising were
selected. These concepts, which included using springs at the cuff and
at the controls, were further developed. Novel ideas of how to get the
cuff to conform to the configuration of the urethra were considered.
These concepts which include two hydraulic designs and three all-mechanical
designs are presented in Figures 3 through 7 with discussions in the
following paragraphs. A matrix of these concepts comparing them with
a product presently on the market is shown in Figure S. The first
concept, i.e., the "Press-Relieve Bulb" model, was selected because
hydraulics appeared to be the most reliable means for precisely con-
trolling the pressure on the urethra while maintaining minimum cuff size.
A. Press/Relief Bulb Concept of a Urinary Prosthetic Sphincter
The press/relieve bulb concept (Fig. 3) would use a forwed cuff
and tube with a large capacity bulb. As shown in Figure 3, to close
the urethra, the bulb would be squeezed. The check valve holds the
fluid in the cuff. Overpressure is relieved by a small relief valve
mounted in the poppet head of the check valve and is bled back to the
bulb through a small hole in the stim. To urinate, the check valve is
"pinched" open as shown in Figure 3.
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The main disadvantage of this concept is the relatively large bulb
required to obtain the necessary volume. However, this does not appear
to be a problem for the scrotum, but would definitely be a problem for
the labia. A modification to the cuff could reduce needed volume.
Figure 3. Press /relieve bulb concept of a urinary prosthetic sphincter.
B. Pressure Band Conce pt of a Urinary Prosthetic Sphincter
The pressure band concept (Fig. 4) uses a cuff filled with very
small glass beads to evenly distribute the compression even over
irregularities of the urethra. Glass beads are used in place of s fluid
simply because this eliminates the failure mode of fluid leakage. To close
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the urethra, a cord attached to the pressure band keeps the cuff com-
pressed against the urethra by the "U" shaped spring. Proper urethral
compression is set at time of installation.
To urinate, a finger and thumb will simply compress the "U" spring
wrdeh releases the pressure on the urethra. Spring must be held for the
duration of urination. A possible disadvantage is that tension in the cord
would cause the tube, to be somewhat stiffer than the tubing in other
models, except during urination.
CLOSED CONFIGURATION
OPEN CONFIGURATION
Figure 4. Pressure band concept of a urinary prosthetic sphincter.
C. Bourdon Tube Concept of a Urinary Prosthetic Sphincter
The Bourdon tube concept (Fig. 5) uses a cuff filled with very
small. glass beads to evenly distribute the compression even over irregu-
larities of the urethra. Glass beads are used in place of a fluid simply
because this eliminates the failure mode of cuff fluid leakage. Due to
the very low volume required to open the Bourdon tribe, a small bulb
can be used. The bulb must be squeezed for the duration of urination.
The main task to develop this concept is to obtain a Bourdon tube
with correct spring rate for urethra compression in conjunction with
variable size spacers for final setting, of compression during installation.
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Figure 5. Bourdon tube concept of a urinary prosthetic sphincter.
D. Spring Cuff Conceot of a Urinary Prosthetic SDhincter
The spring cuff concept (rig. 6) uses a cuff filled with very small
glass beads to evenly distribute the urethra compression even over
irregularities. Glass beads are used in Ulace of i, fluid simply because
this eliminates the failure mode of fluid leakage. A calibrated spring is
used to hold the urethra closed. The compression is released by tension
in the cord from the actuator mechanism. The tension starts to straighten
out the cylinders thus opening up the spring band. Actuator mechanism
is held in squeezed position for duration of urination.
Adjustment of urethral compression would be made during installa-
tion by selection of the right calibrated spring band and adjusting the
cord to remove any excessive slack.
to
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Figure 6. Spring cuff concept of a urinary prosthetic sphincter.
E. Vise Concept of a Urinary Prosthetic Sphincter
The vise concept (Fig. 7) uses a glass filled "pad" on the cuff
housing and one on the piston. Urethral compression is provided by the
calibrated coil spring. To urinate the activation mechanism pulls the
piston off the urethra via the cord. Actuation mechanism must be held
in the squeezed position for the duration of urination.
The main disadvantage is the relatively larger size of the cuff;
however, it would be considerably smaller than shown in the figure.
The cuff housing would need to be designed to allow quick change of
the coil spring during installation to obtain correct urethral compression.
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Figure 7. Vise concept of a urinary prosthetic sphincter.
I11. HARDWARE DEVELOPMENT
The valving concept for the Prosthetic Urinary Sphincter was
created by NASAl11tSFC and given to Parker-Hannifin (PH) for their
design and development because of their unique technology in miniature
valves such as those already developed on the HEAO-B satellite and
Viking space probe.
The Rochester General hospital (RGH) was selected as systems con-
tractor with the following general tasks:
a) Design cuff'.
b) Design complete assembly (valving system provided by PH).
c) Write Product Development Protocol (PDP).
d) Manufacture prototype cuff .
c) Assemble complete prototype units.
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1. MINIMUM SURGERY FOR IMPLANTATION
2. SIMPLICITY FOR MAXIMUM RELIABILITY
I EASE OF ADJUSTING URETHRAL COWRESSION
1. MINIMUM COMPRESSION ORI'T
L FLEXIBILITY OF CONNECTING TUBE
B MANUFACTURABILITY
7. SUSCEPTIBLE TO BLOOD CONTAMINATION
L EASE OF INSTALLATION ASSEMBLY
L MINIMUM CUFF SIZE
1L MINIMUM OPERATOR SIZE
11. ADAPTABLE TO MALE OR FEMALE
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Figure 8. Potential improvement over product
presently on the market.
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f) Bench test units
g) Perform animal implants
h) Perform clinical implants.
RGH has contracted with Dow-Corning to be the System Manu-
facturer to provide the units to be used in the animal implants, with
tentative plans for continued involvement during clinical implants and
ultimately marketing the finished product. This forms the team which
represents the best available technologies in each of the fields required
to produce a marketable prosthetic urinary sphincter that will be
accepted by urologists throughout the world.
Prototypes of the valvinf, system have been manufactured by PH
and have passed fill required bench testing (Fig. 9). There have been
no test failures, which speak:: highly of Parker Hannifin's expertise in
design and manufacturing. The simplicity aspect of reliability in the
valve design is optimized in that one valve seat performs three functions,
serving as a fill check, an over pressure relief, and a pressure release.
Figure 10 presents these functions. Thumb and finger squeeze
bulb through the skin, producing pressure that lifts the ball off its
seat allowing fluid to flow into the cuff which occludes the urethra.
When the thumb and finger are removed, the ball reseats, holding the
pressure in the tuft'.
The pressure in the cuff must be enough to occlude the urethra,
but must not be high enough to overcome the body's blood pressure.
Should this occur the tissue under the cuff would die. To prevent such
an unacceptable occurrence, the second valve function is accomplished
by the over-pressure deflecting the diaphragm against the calibrated
main spring to the point where the ball contacts the housing pedestal.
This nudges the ball off its seat allowing fluid to pass back into the
bulb. At the point where the cuff pressure reaches the calibrated
setting (70 ± 5 inches of water), the cuff pressure/spring force reaches
an equilibrium where the ball reseats and the valve is in a holding mode.
The third function of the valve is to release the pressure in the cuff
when the person chooses to void his or her bladder. This is accomplished
by thumb/finger depressing the plunger which causes the pedestal to lift
the ball off its seat allowing the fluid to flow from the cuff back into the
bulb. The valving system is shown in more detail in Figure 9.
The main hardware design task facing RGH was the cuff, which
had to interface with the human anatomy and be easy to install by the
surgeon. Consideration of the effects of transient pressures caused by
coughing and so forth was also required. The cuff that evolved is a
two-compartment design, with a passive portion that is filled through a
septum for precise fit :after implant. The active compartment is connected
to the valving systcin for pressurizing and releasing to accomplish
14
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bladder control. RGH is also evaluating the amount of tissue ingrowth
into the prosthesis required for anchoring and the potential operational
interference it may cause as opposed to using materials that the body
tends to encapsulate.
Cuff fit-up studies and implant procedures using cadavers, pro-
vide the checkout of prototype hardware and validation of generated
Implant techniques and procedures.
The first prototype cuffs were made by hand lay-up. Later, Dow-
Corning manufactured from the basic RGH design a molded cuff which
appears to be much more compatible with the human body because of its
s"iooth contours when in the installed configuration.
RGH has written the Product Development Protocol (PDP) document
to be submitted to the FDA for approval of this product. This document
is intended to clear up any problems the FDA might have with the pro-
duct so that when the development work is successfully completed,
approval for marketing can be obtained without delay.
IV. CONCLUSION
In light of the satisfactory research and development effort con-
ducted so far, indications are that a successful Prosthetic Urinary
Sphincter will evolve. However, developing a satisfactory product is
not enough to guarantee its use. Even though the potential market for
a prosthetic urinary sphincter is considerably over a million, unless the
product gains general acceptance by medical practitioners it will have
only limited use. This is what happened in earlier attempts to market
similar products. Although these early products had a lot of problems,
in many cases they were very successful. Just as in aerospace, the
medical community is very intolerant of failures. Once a product has
had an unacceptable failure rate, the medical community is slow to give
acceptance even after the product has been vastly improved.
The development process has been very gratifying in that so far
the design ground rules have been met. Thorough testing and vigorous
but responsible marketing procedures must be employed to ensure the
ultimate success of this valuable product.
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